Sutro Biopharma Inc
NASDAQ:STRO

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
NASDAQ:STRO
Watchlist
Price: 1.93 USD 3.21%
Market Cap: 159.1m USD
Have any thoughts about
Sutro Biopharma Inc?
Write Note

Income Statement

Earnings Waterfall
Sutro Biopharma Inc

Revenue
161m USD
Operating Expenses
-291m USD
Operating Income
-130m USD
Other Expenses
6.1m USD
Net Income
-124m USD

Income Statement
Sutro Biopharma Inc

Rotate your device to view
Income Statement
Currency: USD
Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
33
N/A
23
-29%
38
+64%
41
+7%
46
+12%
51
+10%
43
-15%
41
-3%
40
-3%
46
+14%
43
-7%
50
+18%
69
+37%
60
-14%
62
+4%
53
-14%
53
+0%
70
+31%
68
-3%
75
+10%
57
-24%
49
-14%
154
+216%
154
+0%
169
+10%
161
-5%
Operating Income
Operating Expenses
(73)
(72)
(76)
(81)
(87)
(94)
(98)
(102)
(103)
(107)
(114)
(121)
(133)
(148)
(160)
(172)
(181)
(185)
(197)
(207)
(216)
(230)
(243)
(258)
(275)
(291)
Selling, General & Administrative
(17)
(18)
(21)
(25)
(29)
(31)
(33)
(34)
(34)
(35)
(37)
(39)
(43)
(51)
(56)
(60)
(63)
(61)
(60)
(60)
(60)
(61)
(63)
(60)
(57)
(56)
Research & Development
(56)
(55)
(54)
(56)
(59)
(63)
(66)
(68)
(69)
(72)
(77)
(82)
(90)
(97)
(104)
(112)
(119)
(124)
(137)
(147)
(156)
(170)
(180)
(198)
(218)
(235)
Operating Income
(40)
N/A
(49)
-23%
(37)
+24%
(40)
-7%
(41)
-4%
(44)
-6%
(55)
-26%
(60)
-9%
(63)
-5%
(61)
+3%
(71)
-16%
(71)
+0%
(64)
+9%
(88)
-37%
(99)
-12%
(119)
-20%
(128)
-8%
(115)
+10%
(129)
-12%
(132)
-2%
(159)
-20%
(182)
-14%
(89)
+51%
(104)
-16%
(106)
-2%
(130)
-23%
Pre-Tax Income
Interest Income Expense
(1)
(1)
(0)
0
1
0
(0)
(1)
46
74
39
28
(15)
(39)
(7)
4
(3)
(5)
12
5
17
18
13
26
26
50
Total Other Income
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(6)
(13)
(20)
(27)
(29)
Pre-Tax Income
(40)
N/A
(49)
-22%
(35)
+28%
(38)
-6%
(40)
-6%
(42)
-7%
(56)
-31%
(61)
-10%
(17)
+71%
13
N/A
(32)
N/A
(43)
-33%
(79)
-84%
(127)
-61%
(106)
+17%
(114)
-8%
(132)
-15%
(120)
+9%
(117)
+3%
(127)
-9%
(142)
-12%
(170)
-20%
(89)
+48%
(97)
-10%
(107)
-10%
(108)
-1%
Net Income
Tax Provision
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(3)
(3)
(3)
(3)
(1)
(2)
(18)
(18)
(18)
(16)
Income from Continuing Operations
(40)
(49)
(35)
(38)
(40)
(42)
(56)
(61)
(17)
13
(32)
(43)
(79)
(127)
(106)
(114)
(134)
(123)
(119)
(130)
(143)
(172)
(107)
(115)
(124)
(124)
Net Income (Common)
(40)
N/A
(49)
-22%
(35)
+28%
(38)
-6%
(40)
-6%
(42)
-7%
(56)
-31%
(61)
-10%
(17)
+71%
13
N/A
(32)
N/A
(43)
-33%
(79)
-84%
(127)
-61%
(106)
+17%
(114)
-8%
(134)
-17%
(123)
+9%
(119)
+3%
(130)
-9%
(143)
-10%
(172)
-21%
(107)
+38%
(115)
-8%
(124)
-8%
(124)
+0%
EPS (Diluted)
-1.81
N/A
-2.15
-19%
-1.55
+28%
-1.66
-7%
-1.74
-5%
-1.85
-6%
-2.43
-31%
-2.64
-9%
-0.54
+80%
0.33
N/A
-0.99
N/A
-0.93
+6%
-1.71
-84%
-2.75
-61%
-2.29
+17%
-2.46
-7%
-2.85
-16%
-2.34
+18%
-2.35
0%
-2.21
+6%
-2.36
-7%
-2.84
-20%
-1.78
+37%
-1.89
-6%
-1.53
+19%
-1.51
+1%

See Also

Discover More